Ovarian cancer and KiSS-1 gene expression: A consideration of the use of Kisspeptin plus Kisspeptin aptamers in diagnostics and therapy

Keyphrases

• Gene Expression 100%
• Ovarian Cancer 100%
• Kiss1 100%
• Aptamer 100%
• Kisspeptin 100%
• Monoclonal Antibody 33%
• Treatment Options 33%
• Polypeptide 33%
• Distinctive Features 33%
• Clinical Utility 33%
• Therapeutic Approaches 33%
• Ovarian Cancer Patients 33%
• Targeting Moieties 33%
• Adverse Effects 33%
• High Mortality Rate 33%
• Female Population 33%
• In Vitro Study 33%
• Health Burden 33%
• Therapeutic Use 33%
• Aptamer Technology 33%
• Tolerability 33%
• Metastasis 33%
• Survival Rate 33%
• Anatomical Location 33%
• Reproductive System 33%
• Oligonucleotides 33%
• Therapeutic Target 33%
• Gynecological Cancer 33%
• Prophylactic Strategy 33%
• Chemotherapy 33%
• Cancer Growth 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Oligonucleotide 25%